Patents by Inventor Anne Plum

Anne Plum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insulin compositions and method of making a composition
    Patent number: 11167035
    Abstract: The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: November 9, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Svend Havelund, Frantisek Hubalek, Helle Birk Olsen, Ib Jonassen, Thomas Hoeg-Jensen, Anne Plum, Ulla Ribel-Madsen
  • Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide
    Patent number: 8937042
    Abstract: Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: January 20, 2015
    Assignee: Novo Nordisk A/S
    Inventors: Anne Plum, Dorte Bjerre Steensgaard, Jens Kaalby Thomsen, Morten Schlein, Anne Sofie Kajær Markussen, Christian Poulsen
  • INSULIN COMPOSITIONS AND METHOD OF MAKING A COMPOSITION
    Publication number: 20140328943
    Abstract: The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
    Type: Application
    Filed: July 16, 2014
    Publication date: November 6, 2014
    Inventors: Svend Havelund, Frantisek Hubalek, Helle Birk Olsen, Ib Jonassen, Thomas Hoeg-Jensen, Anne Plum, Ulla Ribel-Madsen
  • Pharmaceutical Compositions Comprising GLP-1 Peptides or Extendin-4 and a Basal Insulin Peptide
    Publication number: 20110152185
    Abstract: Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.
    Type: Application
    Filed: November 14, 2008
    Publication date: June 23, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Anne Plum, Dorte Bjerre Steensgaard, Jens Kaalby Thomsen, Morten Schlein, Anne Sofie Kajaer Markussen, Christian Poulsen
  • INSULIN COMPOSITIONS AND METHOD OF MAKING A COMPOSITION
    Publication number: 20090074882
    Abstract: The invention is related to insulin compositions with a high content of zinc atoms per six molecules of acylated insulin. The insulin is an acylated insulin and may be mixed with a further insulin analogue such as the rapid acting insulin Asp B28 human insulin.
    Type: Application
    Filed: December 21, 2006
    Publication date: March 19, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Svend Havelund, Frantisek Hubalek, Helle Birk Olsen, Ib Jonassen, Thomas Hoeg-Jensen, Anne Plum, Ulla Ribel-Madsen